Your Business Has Symptoms. Do You Know the Cause?

Moving from one country to another has a way of making you question what you thought you knew about business. The market changes. Negotiations feel different. Relationships carry different weight. Customers ask different questions. A commercial approach that worked perfectly in one country can fall flat in another.

At first, I thought the rules had changed. They hadn't. The environment had. The fundamentals had not.

Customers still need a reason to buy. Revenue still needs margin. Profit eventually needs to become cash. Operations still have to deliver what sales promised. And strategy still comes down to a handful of difficult choices: where to compete, how to win and what not to do.

What changes dramatically is how problems reveal themselves.

After years working across business development, international marketing and strategy, I have become wary of sentences that begin with "Our problem is..." — sales, marketing, cash flow, the team, financing. Perhaps. But what management calls a problem is often only a symptom. And treating a symptom can be expensive.

The Obvious Answer Is Often the Dangerous One

Suppose sales fall 20%. The response is almost predictable. Hire more salespeople. Increase the marketing budget. Offer discounts. Push harder. By the end of the meeting, everyone has something to do. But nobody has answered the most important question: why did sales fall?

Maybe the company lacks leads. Maybe it has plenty of leads, but they are the wrong ones. Maybe customers want the product but reject the price. Maybe the price is fine, but quotations require four days of internal approval while a competitor replies in four hours. Maybe new customers are arriving, but late deliveries mean they never order twice. Maybe the market has simply moved on.

Every one of those problems can produce the same line on a management dashboard: Sales: -20%. They require entirely different treatments. Hiring salespeople solves only one of them. For some of the others, it could actually make things worse.

Companies Have Departments. Problems Don't.

This is where diagnosis becomes difficult. Imagine a salesperson wins a major customer by offering 90-day payment terms. Sales celebrates. Revenue rises. The pipeline looks healthier. Meanwhile, the company pays suppliers, freight, salaries and operating expenses long before the customer's money arrives. Growth accelerates. Cash gets tighter. Eventually finance announces a working-capital problem and management starts looking for another credit facility.

But was it really a financing problem? Or did it begin months earlier with a commercial decision?

The distinction matters. A sales problem can begin in pricing. A cash problem can begin in commercial terms. An operational problem can originate in sales incentives. What looks like poor employee performance can be the result of badly designed decision-making. And sometimes a company is not executing badly at all — it is executing the wrong strategy remarkably well.

Think Like a Diagnostician

Before asking "What should we do?", I prefer a different sequence: Symptom → Possible Causes → Questions → Evidence → Root Cause → Treatment. Think of it as a Business Health Map, looking across seven areas.

Commercial: Are we creating profitable revenue or simply more volume?
Sales: Where exactly do prospects disappear — lead generation, qualification, proposal, negotiation, closing or repeat purchase?
Financial: Where does cash get trapped — receivables, inventory, weak margins or poor payment terms?
Operations: Can we consistently deliver what we sell?
Market: Have customers, competitors, technology or regulation changed the game?
Management: Where do decisions get stuck?
Strategy: Are we executing badly, or pursuing the wrong opportunity?

Take our 20% sales decline again. Perhaps pricing has become uncompetitive. Perhaps qualified leads have collapsed. Perhaps credit restrictions are blocking viable orders. Perhaps delivery failures are destroying repeat business. Perhaps customers have moved to a substitute. Perhaps quotations require so many approvals that competitors get there first. Perhaps the company is targeting a market where it has no meaningful advantage.

One symptom. Seven plausible diagnoses. Seven very different decisions.

Evidence Is More Useful Than Confidence

One discipline has become particularly valuable to me in strategy work: treat strong opinions as hypotheses, not facts.

"The market is bad." Show me the market data. "Our prices are too high." Show me conversion at different price points. "We need more people." Show me capacity utilisation. "Customers only care about price." Let's talk to the customers we lost. "Our salespeople are weak." Show me conversion by salesperson, product, segment and funnel stage.

This is not analysis for the sake of analysis. It is protection against expensive assumptions. Every executive sees the company through a different window. Finance sees cash. Sales sees opportunities. Operations sees bottlenecks. Marketing sees customers. The CEO sees priorities. Each view may be correct. None is necessarily complete.

Five Questions I Would Ask Tomorrow Morning

If I had one morning to understand a business, I would start here:

1. Where do we actually make money? Not revenue. Profit — by customer, product, market and channel.
2. Where does our cash get stuck?
3. At exactly which point do customers disappear?
4. Which recurring decisions take too long, and who must approve them?
5. What breaks if the CEO disappears for 30 days? Which deals stop? Which payments wait? Which customers call? Which decisions freeze?

The answer to that last question tells you something a P&L never will: how much of the business belongs to the organisation — and how much still lives inside one person's head.

Diagnosis Before Treatment

This is why I find the idea of a Business Clinic useful. Not because a company is a patient, but because the discipline is similar. A good doctor does not see pain and immediately prescribe surgery. There is evidence. There are possible explanations. There are tests. There is a diagnosis. Then there is treatment.

Businesses deserve the same sequence: evidence, hypotheses, cross-functional diagnosis, root cause, priorities, treatment.

Moving between countries taught me how dramatically markets can differ on the surface. It also taught me how stubbornly the fundamentals remain the same underneath. Businesses still have to create value, convert it into healthy economics, organise people around clear decisions and adapt when markets move.

So I have learned to be cautious when someone tells me immediately what a company's problem is. I am much more interested when they can show me why.

Before the next hiring plan, expansion, restructuring, loan or technology investment, there is one question worth asking first: what is actually wrong? A structured diagnostic conversation with QAA's Business Clinic is exactly where that question gets answered.

Because treatment before diagnosis isn't strategy. It's a guess.